Ontario’s COVID-19 Genomics Rapid Response Coalition 



To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.



Standardized Sequencing Methodologies



Data Management & Sharing

The ON-CoV Coalition is designed to provide for method standardization and coordination of:


Collecting Patient Samples and Metadata




Data Curation and Management


Epidemiological Studies 

This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.

Why Genomics?

Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19

pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19. 

The results reported by the Coalition will inform vaccine and therapeutic development.

Why Ontario Genomics?

Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms. 

Ontario Genomics is well-positioned to provide and promote:


ONCoV Genomics Coalition Members

Bettina Hamelin

Ontario Genomics

Andrew G. McArthur

McMaster University

Stephen Scherer

Hospital for Sick Children / University of Toronto


Aaron Campigotto

University of Toronto

Letitia Nadalin Penno

Canadore College

Nahuel Fittipaldi

Public Health Ontario

Allison McGeer

Sinai Health Systems

Jared Simpson

Ontario Institute for Cancer Research

Danielle Brabant-Kirwan

Health Sciences North

Prameet M. Sheth

Kingston Health Sciences Centre / Queen’s University

Robyn Lee

Dalla Lana School of Public Health, University of Toronto

Samira Mubareka

Sunnybrook Health Sciences / University of Toronto

Michael Szego

Unity Health Toronto / University of Toronto

Marc Fiume


David Villeneuve

Canadore College

Bo Wang

Peter Munk Cardiac Centre, UHN / University of Toronto


We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.




Public Policy Forum Podcast: Understanding a Disease – COVID-19 and Genomics Canada Podcast

June 1, 2020

COVID-19 is a virus that impacts different individuals in similar ways. In this podcast, Dr. Bettina Hamelin, President & CEO of Ontario Genomics and Dr. Rob Annan, President & CEO of Genome Canada explore the scientific aspects of COVID-19 dynamics and how it affects individuals.

Hospital News: Dr. Samira Mubareka - It’s all in the genome: Preparing for the next waves of COVID-19

May 28, 2020

On January 24th, Sunnybrook Health Sciences admitted the first Canadian patient with COVID-19. The traveller had just returned from Wuhan, China, the epicentre of the virus outbreak. He presented with a respiratory illness due to SARS-CoV-2, the coronavirus that causes COVID-19. At that moment I realized this virus would come to dominate our reality, both at Sunnybrook and across Canada.

COVID-19 Research: Genomics, Rapid Execution & Funding featuring Samira Mubareka

Ontario’s infectious disease expert speaks about her COVID-19 research in an interview with TheFuturEconomy.ca. Leading Sunnybrook’s Coronavirus response, her work on isolating & understanding the virus is helping roll out rapid research efforts.

April 27, 2020



© 2020 by Ontario Genomics